Dr. Scott Hauswirth, OD

Dr. Scott Hauswirth is currently a Senior Director of Clinical Development, Ophthalmology for Dompe Farmaceutici, S.p.A, a global biotech company focused on providing solutions for challenging conditions and unmet medical needs in ophthalmology, neurology, and pain. He functions as the Global Development Lead for a novel ophthalmology asset in early clinical development, and supports additional pipeline programs as a clinical medical expert.

Dr. Hauswirth finished optometry school at the Southern California College of Optometry (now Marshall B. Ketchum University) and completed a one-year residency in Cornea, Glaucoma, and Refractive Surgery Management at Minnesota Eye Consultants in Minneapolis. He then was invited to join the staff at Minnesota Eye and practiced as a consultative optometrist for 17 years, treating patients in the community in addition to creating the optometric student externship program, becoming heavily involved in the clinical research department.

He then became an associate professor of ophthalmology at the University of Colorado School of Medicine, directing the Ocular Surface Clinic and joining the Faculty of Ocular Inflammation, managing patients with severe ocular surface inflammatory disease, in addition to continuing his research endeavors before his transition to industry.

Dr. Hauswirth has published numerous peer-reviewed articles, book chapters, and has been an avid lecturer at state, national, and international conferences; he has participated in over 100 clinical trials as a principal- or sub-investigator, was a founding member of the INTREPID optometric society, and achieved the prestigious diplomate status at the American Academy of Optometry, where he served in various leadership roles in the Anterior Segment Section.

Dr. Hauswirth currently resides in Southwest Florida where he enjoys being on the water and spending time with his family.